OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

2 Projects | 1 Researchers | $200,000 Invested

2008

Memorial Sloan Kettering Cancer Center

Gabriela Chiosis, PhD

Hsp90 inhibitors in tauopathies: in vivo pre-clinical development

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2007

Memorial Sloan Kettering Cancer Center

Gabriela Chiosis, PhD

Development of Hsp90 inhibitors as novel therapeutics for AD

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed